ATE187172T1 - Chinolin-2-on derivate als serotonin antagonisten - Google Patents

Chinolin-2-on derivate als serotonin antagonisten

Info

Publication number
ATE187172T1
ATE187172T1 AT96931112T AT96931112T ATE187172T1 AT E187172 T1 ATE187172 T1 AT E187172T1 AT 96931112 T AT96931112 T AT 96931112T AT 96931112 T AT96931112 T AT 96931112T AT E187172 T1 ATE187172 T1 AT E187172T1
Authority
AT
Austria
Prior art keywords
quinolin
derivatives
serotonin antagonists
serotonin
antagonists
Prior art date
Application number
AT96931112T
Other languages
English (en)
Inventor
Cort Gary Mc
Christian Hoornaert
Genevieve Dellac
Michel Aletru
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510815A external-priority patent/FR2738822B1/fr
Priority claimed from FR9511083A external-priority patent/FR2739100B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE187172T1 publication Critical patent/ATE187172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96931112T 1995-09-15 1996-09-12 Chinolin-2-on derivate als serotonin antagonisten ATE187172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9510815A FR2738822B1 (fr) 1995-09-15 1995-09-15 Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR9511083A FR2739100B1 (fr) 1995-09-21 1995-09-21 Derives de 4-(omega-(4-(4-fluorobenzoyl)piperidin-1-yl)- alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ATE187172T1 true ATE187172T1 (de) 1999-12-15

Family

ID=26232206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931112T ATE187172T1 (de) 1995-09-15 1996-09-12 Chinolin-2-on derivate als serotonin antagonisten

Country Status (29)

Country Link
US (1) US5958924A (de)
EP (1) EP0850235B1 (de)
JP (1) JP3335362B2 (de)
KR (1) KR100422850B1 (de)
CN (1) CN1094490C (de)
AR (1) AR003996A1 (de)
AT (1) ATE187172T1 (de)
AU (1) AU715879B2 (de)
BG (1) BG63779B1 (de)
BR (1) BR9610579A (de)
CA (1) CA2228038C (de)
CO (1) CO4750663A1 (de)
CZ (1) CZ288149B6 (de)
DE (1) DE69605430T2 (de)
DK (1) DK0850235T3 (de)
EE (1) EE04116B1 (de)
ES (1) ES2142089T3 (de)
GR (1) GR3032618T3 (de)
HU (1) HU222745B1 (de)
IL (1) IL123600A (de)
NO (1) NO323841B1 (de)
NZ (1) NZ318436A (de)
PL (1) PL184808B1 (de)
RU (1) RU2167874C2 (de)
SI (1) SI0850235T1 (de)
SK (1) SK282222B6 (de)
TR (1) TR199800464T1 (de)
UA (1) UA44332C2 (de)
WO (1) WO1997010238A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2142089T3 (es) * 1995-09-15 2000-04-01 Sanofi Synthelabo Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica.
FR2761067B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR0107732A (pt) * 2000-01-20 2003-03-11 Eisai Ltd Método para prevenir ou tratar uma doença
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
RU2267485C2 (ru) * 2003-10-07 2006-01-10 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Производные 3-аминометилхинолона-2 в качестве ингибиторов no-синтетазы и способ их получения, биологически активные соединения и фармацевтическая композиция на их основе
RU2284325C2 (ru) * 2003-12-17 2006-09-27 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
FR2909670B1 (fr) 2006-12-12 2010-07-30 Sanofi Aventis Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
PL2200985T3 (pl) 2007-09-14 2011-12-30 Ortho Mcneil Janssen Pharmaceuticals Inc 1,3-Dipodstawione-4-(arylo-X-fenylo)-1H-pirydyn-2-ony
SI2203439T1 (sl) 2007-09-14 2011-05-31 Ortho Mcneil Janssen Pharm 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
EP2344470B1 (de) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexylderivate als modulatoren von metabotropen glutamatrezeptoren
NZ592008A (en) * 2008-10-02 2011-12-22 Taisho Pharmaceutical Co Ltd 7-piperidinoalkyl-3,4-dihydroquinolone derivative
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
CN102439008B (zh) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
MX386697B (es) 2014-01-21 2025-03-19 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
ME03518B (de) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
IL287136B2 (en) 2016-02-05 2023-09-01 Denali Therapeutics Inc Receptor inhibitors - interacting with protein kinase 1
JP7208137B2 (ja) 2016-12-09 2023-01-18 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
CN108707109A (zh) * 2018-08-29 2018-10-26 常州沃腾化工科技有限公司 一种2-甲氧基-4-三氟甲基吡啶-3-磺酰氯的制备方法
TW202334164A (zh) 2022-01-12 2023-09-01 美商戴納立製藥公司 （Ｓ）－５－苄基－Ｎ－（５－甲基－４－側氧基－２，３，４，５－四氫吡啶並［３，２－ｂ］［１，４］氧氮呯－３－基）－４Ｈ－１，２，４－三唑－３－甲醯胺的晶型

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2345422C2 (de) * 1973-09-08 1983-12-22 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte Isochinolyl-arylpiperazine diese enthaltende Arzneimittel sowie Verfahren zu deren Herstellung
NL8001369A (nl) * 1980-03-06 1981-10-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen.
IT1155357B (it) * 1982-07-06 1987-01-28 Ravizza Spa Processo per la preparazione della kentanserina
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
RU1774624C (ru) * 1990-11-11 1995-02-09 Украинская фармацевтическая академия Диэтиламиноэтиламида 1-пропил-2-оксо-4-гидроксихинолин-3-карбоновой кислоты гидрохлорид, проявляющий анестезирующую, противоаритмическую, антиоксидантную, антимикробную и фунгицидную активность
US5457099A (en) * 1992-07-02 1995-10-10 Sawai Pharmaceutical Co., Ltd. Carbostyril derivatives and antiallergic agent
ES2142089T3 (es) * 1995-09-15 2000-04-01 Sanofi Synthelabo Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica.

Also Published As

Publication number Publication date
EP0850235A1 (de) 1998-07-01
KR19990044666A (ko) 1999-06-25
HUP9802940A2 (hu) 1999-05-28
JP3335362B2 (ja) 2002-10-15
AU6991996A (en) 1997-04-01
EE04116B1 (et) 2003-08-15
RU2167874C2 (ru) 2001-05-27
AR003996A1 (es) 1998-09-30
EP0850235B1 (de) 1999-12-01
CA2228038A1 (en) 1997-03-20
SK34698A3 (en) 1998-08-05
DE69605430T2 (de) 2000-07-13
US5958924A (en) 1999-09-28
JPH11514982A (ja) 1999-12-21
CN1202168A (zh) 1998-12-16
HU222745B1 (hu) 2003-09-29
HUP9802940A3 (en) 2001-11-28
GR3032618T3 (en) 2000-05-31
DE69605430D1 (de) 2000-01-05
TR199800464T1 (xx) 1998-05-21
AU715879B2 (en) 2000-02-10
IL123600A0 (en) 1998-10-30
CZ288149B6 (en) 2001-05-16
NO323841B1 (no) 2007-07-09
BR9610579A (pt) 1999-07-06
BG102316A (en) 1999-03-31
ES2142089T3 (es) 2000-04-01
SK282222B6 (sk) 2001-12-03
DK0850235T3 (da) 2000-05-29
CA2228038C (en) 2009-04-21
UA44332C2 (uk) 2002-02-15
CN1094490C (zh) 2002-11-20
NZ318436A (en) 1999-02-25
EE9800089A (et) 1998-10-15
PL184808B1 (pl) 2002-12-31
NO981141D0 (no) 1998-03-13
PL325467A1 (en) 1998-07-20
IL123600A (en) 2001-05-20
KR100422850B1 (ko) 2004-07-23
MX9802028A (es) 1998-09-30
WO1997010238A1 (fr) 1997-03-20
HK1014868A1 (en) 1999-10-08
NO981141L (no) 1998-05-15
CO4750663A1 (es) 1999-03-31
BG63779B1 (bg) 2002-12-29
CZ78698A3 (cs) 1998-06-17
SI0850235T1 (en) 2000-04-30

Similar Documents

Publication Publication Date Title
ATE187172T1 (de) Chinolin-2-on derivate als serotonin antagonisten
ATE216999T1 (de) Pyrimidin-4-on derivate als pestizidesmittel
ATE149163T1 (de) Indolin derivate als 5ht2c antagonisten
ATE321037T1 (de) Als antikrebsmittel verwendbare alkinyl- substituierte chinolin-2-on-derivate
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
FI970310L (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
ATE246677T1 (de) Chinolinderivate als tachykinin nk3 rezeptor antagonisten
FI944734A7 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
ATE197300T1 (de) Indolderivate als 5-ht rezeptorantagoniste
DE69325167D1 (de) Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
ATE289994T1 (de) Chinolin-derivate
DE69714265D1 (de) Tetrahydrochinolinderivate als eaa antagonisten
NO974043D0 (no) Indolderivater som EAA-antagonister
ATE254621T1 (de) Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
ATE325118T1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
DE69709869D1 (de) BENZO[g]CHINOLIN DERIVATE
FI970143A7 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
KR950700884A (ko) 루코트리엔 길항제로서의 퀴놀린 유도체(Quinoline derivatives as leukotriene antagonists)
FI963463L (fi) Indolijohdannaiset CCK-reseptoriantagonisteina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification